{"id":"W2141501933","doi":"10.1136/thoraxjnl-2012-202606","title":"Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β<sub>2</sub>agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial","year":2013,"lang":"en","type":"article","venue":"Thorax","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hamilton Health Sciences","funders":"UCB Pharma; National Institute for Health and Care Research; Teva Pharmaceutical Industries; Genentech; AstraZeneca; Amgen; Pfizer; GlaxoSmithKline","keywords":"Medicine; Fluticasone propionate; Tolerability; Asthma; Corticosteroid; Adverse effect; Internal medicine; Gastroenterology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002464093,0.001271744,0.002917981,0.0003578833,0.0003945352,0.001239982,0.0009337945,0.002309671,0.006112726],"category_scores_gemma":[0.002217253,0.0007905723,0.003154117,0.00036086,0.001042842,0.0009362391,0.0004510586,0.002732454,0.001040277],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008537715,"about_ca_system_score_gemma":0.0008742798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007976228,"about_ca_topic_score_gemma":0.001600925,"domain_scores_codex":[0.9989281,0.0005394046,0.0001096386,0.0001782798,0.00009815932,0.0001463409],"domain_scores_gemma":[0.9982885,0.0005126503,0.0005272435,0.0001162469,0.0001082888,0.0004471332],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9829081,0.003367666,0.0008118481,0.0007229612,0.0009522174,0.00004049966,0.00004380787,0.0001336386,0.002183704,0.00002357787,0.0002199589,0.008591922],"study_design_scores_gemma":[0.8903183,0.1051831,0.002928648,0.00005277481,0.0006840721,0.00005398348,0.0000233653,0.0001353612,0.0002411215,0.00003946861,0.0003275643,0.0000123258],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9889958,0.006689876,0.000258789,0.0004110169,0.0003723436,0.001787873,0.0005245428,0.00004084648,0.0009190324],"genre_scores_gemma":[0.9911944,0.003309306,0.0005910734,0.0005861871,0.0004906545,0.001977232,0.0005849002,0.00001159725,0.001254727],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006112726,"threshold_uncertainty_score":0.0204491,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01108943881476582,"score_gpt":0.2355578585111051,"score_spread":0.2244684196963393,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}